New Horizons Forum
Thanks for emailing that article!
The 5th Annual New Horizons Forum: speeding the development of new therapies and diagnostics for glaucoma patients.
January 29, 2016 — The Palace Hotel, San Francisco, California
The centerpiece of Glaucoma 360, the New Horizons Forum unites key clinical, industry, financial, and FDA leaders in a unique exchange on research innovation and advances in glaucoma treatment.
Launched in 2012 by the Glaucoma Research Foundation, this catalyst meeting is designed to bring the essential components together in order to speed the translation of new ideas into clinical practice.
What others are saying about New Horizons Forum:
"New Horizons is an interdisciplinary meeting and ophthalmologists can learn so much from colleagues with a different perspective. Our ophthalmic community is at its most vibrant when we collaborate and share ideas. New Horizons is where this happens."
- Ruth D. Williams, MD, President, Wheaton Eye Clinic
"The best meeting to learn about what's really new in glaucoma."
- Ahmad A. Aref, MD, Illinois Eye and Ear Infirmary
"A great introduction to emerging technologies together with the opportunity to meet the innovators."
- John Maroney, CEO, ForSight Vision 5
Who should attend:
- Early-stage company CEOs and executives
- Business Development and other representatives from companies that offer pharmaceuticals, devices, drug delivery, and IOP monitoring for glaucoma patients
- Key Opinion Leaders and Leading Ophthalmologists
- Industry Executives
- Venture Capitalists
- Representatives from Clinical Research Organizations
- Scientific innovators
Founder and Co-Chair
Adrienne Graves, PhD
Independent Director: Aerpio Therapeutics, Akorn, Inc., Encore Vision, Inc., Envisia Therapeutics, Nicox S.A., and TearLab Corporation
Founder and Co-Chair
Andrew G. Iwach, MD
Glaucoma Center of San Francisco
New Horizons Advisory Board
Stuart B. Abelson, MBA
President, Chief Executive Officer, Ora, Inc.
Anthony P. Adamis, MD
Vice President, Global Head of Ophthalmology, Genentech, Inc.
President and CEO, PanOptica, Inc.
George A. Cioffi, MD
Chairman, Department of Ophthalmology
Columbia University College of Physicians and Surgeons
Alan Crandall, MD
Director of Glaucoma and Cataract, Senior Vice Chairman of Ophthalmology & Visual Sciences
John A. Moran Eye Center, University of Utah
Emmett Cunningham, Jr., MD, PhD, MPH
Partner, Clarus Ventures
Eugene de Juan, Jr., MD
Founder and Vice-Chairman, ForSight Labs
John W. Grunden, PharmD
Regional Director of Medical Affairs for Ophthalmology (USA/EU/Can)
Merck & Co., Inc.
David Guyer, MD
Partner, SV Life Sciences Advisers, LLC
Eve Higginbotham, SM, MD
Vice Dean, Perelman School of Medicine, University of Pennsylvania
Co-founder and Director, ROI Squared LLC
H. Dunbar Hoskins, Jr., MD
Co-Founder and Director of Glaucoma Research Foundation, and
Former Executive Vice President, American Academy of Ophthalmology
General Partner, Canaan Partners
Ralf Kuschnereit, PhD
President and Chief Executive Officer, Carl Zeiss Meditec Inc.
Eliot Lazar, MD
President, elCON Medical
Paul Lee, MD, JD
F. Bruce Fralick Professor and Chair, Department of Ophthalmology and Visual Sciences and Director, W.K. Kellogg Eye Center, University of Michigan
Richard Lindstrom, MD
Founder, Minnesota Eye Consultants, PA
William J. Link, PhD
Managing Director, Versant Ventures
Sabri Markabi, MD
Sr. Vice President, Research & Development, and Chief Medical Officer
Alcon Laboratories, Inc.
Operating Partner, Versant Ventures
Chairman and CEO, AcuFocus
J. Casey McGlynn, JD
Partner, Wilson Sonsini Goodrich & Rosati
Gary D. Novack, PhD
President, PharmaLogic Development, Inc.
David E. I. Pyott
Chairman of the Board, President and Chief Executive Officer
Thomas W. Samuelson, MD
Founding Partner, Minnesota Eye Consultants
Adjunct Associate Professor of Ophthalmology, University of Minnesota
Murthy V. Simhambhatla, PhD
President, Abbott Medical Optics
Senior Vice President, Abbott Laboratories
Kuldev Singh, MD, MPH
Professor of Ophthalmology and Director, Glaucoma Service
Stanford University Medical Center
Ellen Strahlman, MD, MHSc
Chief Medical Officer and Senior Vice President, Research & Development,
Becton, Dickinson and Company
Vice President, Pharmaceutical Marketing
Bausch + Lomb
Robert N. Weinreb, MD
Chairman & Distinguished Professor of Ophthalmology, Director, Shiley Eye Center, Director, Hamilton Glaucoma Center, Morris Gleich MD Chair of Glaucoma,
University of California, San Diego
Ruth D. Williams, MD
President, Wheaton Eye Clinic
M. Roy Wilson, MD
President, Wayne State University
The 5th annual New Horizons Forum, a full-day program, will take place January 29, 2016 at The Palace Hotel in San Francisco.
7:30 AM - Registration, Breakfast, and Exhibits
8:00 AM to 5:30 PM - Program
5:30 PM to 7:00 PM - Reception
New Horizons Exhibit Hall — 7:30 AM to 7:00 PM
For sponsorship opportunities, please contact Aileen Trieu at Glaucoma Research Foundation at (415) 986-3162.
All Glaucoma 360 events are held at the historic Palace Hotel in San Francisco, California. The Palace is an iconic landmark venue featuring timeless creations such as the Garden Court's stained glass dome and a 1909 Maxfield Parrish mural in the Pied Piper Bar. The Palace Hotel is a full-service destination that offers elegant accommodations, esteemed restaurants and opulent meeting spaces.
The Palace Hotel
2 New Montgomery St, San Francisco, CA 94105
Phone: (415) 512-1111
For more information, please email Aileen Trieu at Glaucoma Research Foundation, or call (415) 986-3162.
Proceeds from the New Horizons Forum benefit the Glaucoma Research Foundation for use in our grant-making and other operational priorities.
Last reviewed on February 10, 2015